Skip to main content
Clinical Trials/NCT06819202
NCT06819202Not yet recruitingNot Applicable

Effect of Hyperbaric Oxygen Therapy on Patients With Sudden Sensorineural Hearing Loss and Coagulation Function

Sun Yuting1 site in 1 country1,309 target enrollmentStarted: June 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
1,309
Locations
1
Primary Endpoint
Hearing recovery rate

Study Overview

Brief Summary

The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis.

The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL.

The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Meet the diagnostic criteria for sudden deafness in the American Academy of Otolaryngology Head and Neck Surgery 2019 Clinical Practice Guidelines for Sudden Deafness;
  • Aged 18-75 years old;
  • Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.

Exclusion Criteria

  • Patients with other ear diseases, such as auditory trauma, barotrauma, retrocochlear disease, bilateral hearing loss, history of chronic otitis media in the same ear, and history of surgery in the same ear;
  • Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases;
  • Pregnant and nursing patients;
  • Accompanied by serious mental illness;
  • Patients with incomplete clinical data.

Outcomes

Primary Outcomes

Hearing recovery rate

Time Frame: From onset to 3 months after treatment

The rate of hearing recovery in patients with all levels of hearing loss at completion of treatment and at 3 months after termination of treatment was assessed according to the WHO Hearing Loss Rating Criteria 2021 to determine the success of treatment.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sun Yuting
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Sun Yuting

PhD student

Shanghai University of Traditional Chinese Medicine

Study Sites (1)

Loading locations...

Similar Trials

Effect of Hyperbaric Oxygen Therapy(HBOT)... | Clinical Trial